Šalis: Airija
kalba: anglų
Šaltinis: HPRA (Health Products Regulatory Authority)
Infectious bronchitis virus strain M41; Infectious bronchitis virus strain 249g ; Avian rhinotracheitis virus strain But1 #8544 (subgroup A); Infectious bursal disease virus strain D78; Newcastle disease virus strain clone 30
Intervet Ireland Limited
QI01AA18
Infectious bronchitis virus strain M41; Infectious bronchitis virus strain 249g ; Avian rhinotracheitis virus strain But1 #8544 (subgroup A); Infectious bursal disease virus strain D78; Newcastle disease virus strain clone 30
.
Emulsion for injection
POM: Prescription Only Medicine as defined in relevant national legislation
Chickens
avian infectious bronchitis virus + newcastle disease virus / paramyxovirus + avian adenovirus + avian rhinotracheitis virus
Immunological - Inactivated Vaccine
Authorised
2000-08-24
1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobilis RT+IBmulti+G+ND emulsion for injection for chickens 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 0.5 ml dose contains: ACTIVE SUBSTANCES: Inactivated viral antigens of: AMPV strain But1# 8544: inducing 9.5 log 2 ELISA units* IBV strain M41(Massachusetts): inducing 5.5 log 2 VN units* IBV strain 249g (D274/D207): inducing 4.0 log 2 VN units* IBDV strain D78: inducing 14.5 log 2 VN units* NDV strain Clone 30: inducing 4.0 log 2 HI units per 1/50 th dose* or containing 50 PD 50 units * serological response in chickens ADJUVANT: Liquid paraffin: 215 mg EXCIPIENTS: QUALITATIVE COMPOSITION OF EXCIPIENTS AND OTHER CONSTITUENTS Polysorbate 80 Sorbitan mono-oleate Glycine Water for injections White to nearly white oily emulsion. 3. CLINICAL INFORMATION 3.1 TARGET SPECIES Chickens (future breeders). 3.2 INDICATIONS FOR USE FOR EACH TARGET SPECIES Active immunisation of breeder chickens for: - reduction of infection and prevention of egg drop caused by the Massachusetts serotype of infectious bronchitis virus (IBV); - reduction of egg drop and eggshell defects caused by the D274/D207 serotype of infectious bronchitis virus (IBV); - reduction of infection caused by Newcastle disease virus (NDV); - prevention of respiratory signs and reduction of egg drop and eggshell defects related to avian metapneumovirus (AMPV); - passive immunisation of the progeny of the vaccinated birds against infectious bursal disease virus (IBDV). Onset of immunity: • IBV, NDV, AMPV: 4 weeks post-vaccination • IBDV in progeny: 1 day of age Duration of immunity: • IBV, NDV, AMPV: one laying period • IBDV in progeny: 4 weeks 3.3 CONTRAINDICATIONS None. 3.4 SPECIAL WARNINGS Vaccinate healthy animals only. 3.5 SPECIAL PRECAUTIONS FOR USE Special precautions for safe use in the target species: Vaccination with inactivated vaccine will not completely prevent shedding of wild type virus after infection. Therefore, this vaccine is only meant to reduce the clinical signs Perskaitykite visą dokumentą